8897.T
Takara Leben Co., Ltd. [8897.T] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
8897.T Stock Summary
Top 10 Correlated ETFs
8897.T
Top 10 Correlated Stocks
8897.T
In the News
8897.T Financial details
Company Rating
Strong Buy
Market Cap
47.55B
Income
4.21B
Revenue
157.78B
Book val./share
540.83
Cash/share
363.28
Dividend
6
Dividend %
1.38%
Employees
1.2K
Optionable
No
Shortable
Yes
Earnings
27 Jul 2023
P/E
11.3
Forward P/E
-
PEG
-10.73
P/S
0.3
P/B
0.81
P/C
1.2
P/FCF
-
Quick Ratio
0.33
Current Ratio
1.51
Debt / Equity
3.99
LT Debt / Equity
2.4
-
-
EPS (TTM)
38.67
EPS next Y
-
EPS next Q
-
EPS this Y
32.11%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-3.47%
Revenue last 5Y
7.98%
Revenue Q/Q
-52.13%
EPS Q/Q
-147.94%
-
-
-
-
SMA20
10.29%
SMA50
12.22%
SMA100
15.16%
Inst Own
-
Inst Trans
-
ROA
1%
ROE
7%
ROC
0.04%
Gross Margin
20%
Oper. Margin
5%
Profit Margin
3%
Payout
-
Shs Outstand
109.05M
Shs Float
81.48M
-
-
-
-
Target Price
-
52W Range
327.0-440.0
52W High
-1.14%
52W Low
+33.03%
RSI
66.96
Rel Volume
1.15
Avg Volume
360.49K
Volume
415.7K
Perf Week
4.32%
Perf Month
14.78%
Perf Quarter
15.08%
Perf Half Y
13.87%
-
-
-
-
Beta
0.474274
-
-
Volatility
6.73%, 18.74%
Prev Close
1.64%
Price
435
Change
0.69%
8897.T Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-03-31
| Metric | History | 2018-03-31 | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 |
|---|---|---|---|---|---|---|
| Revenue per share | 1.02K | 1.22K | 1.55K | 1.37K | 1.5K | |
| Net income per share | 68.12 | 59.32 | 49.45 | 43.22 | 57.09 | |
| Operating cash flow per share | 91.25 | 207.05 | 440.06 | 242.47 | 213.03 | |
| Free cash flow per share | -188.68 | -74.69 | 168.14 | 4.28 | -22.92 | |
| Cash per share | 270.2 | 195.39 | 325.71 | 360.7 | 307.09 | |
| Book value per share | 396.7 | 438.84 | 469.27 | 500.88 | 544.82 | |
| Tangible book value per share | 379.95 | 423.64 | 455.19 | 488.34 | 524.46 | |
| Share holders equity per share | 396.7 | 438.84 | 469.27 | 500.88 | 544.82 | |
| Interest debt per share | 996.05 | 1.04K | 1.06K | 1.1K | 1.19K | |
| Market cap | 49.75B | 38.02B | 37.84B | 40.5B | 32.55B | |
| Enterprise value | 127.19B | 128.67B | 116.56B | 119.9B | 127.09B | |
| P/E ratio | 6.75 | 5.92 | 7.06 | 8.63 | 5.24 | |
| Price to sales ratio | 0.45 | 0.29 | 0.22 | 0.27 | 0.2 | |
| POCF ratio | 5.04 | 1.7 | 0.79 | 1.54 | 1.4 | |
| PFCF ratio | -2.44 | -4.7 | 2.08 | 87.11 | -13.05 | |
| P/B Ratio | 1.16 | 0.8 | 0.74 | 0.74 | 0.55 | |
| PTB ratio | 1.16 | 0.8 | 0.74 | 0.74 | 0.55 | |
| EV to sales | 1.15 | 0.97 | 0.69 | 0.81 | 0.78 | |
| Enterprise value over EBITDA | 9.08 | 9.93 | 7.98 | 9.09 | 8.37 | |
| EV to operating cash flow | 12.89 | 5.74 | 2.44 | 4.55 | 5.48 | |
| EV to free cash flow | -6.23 | -15.91 | 6.39 | 257.86 | -50.94 | |
| Earnings yield | 0.15 | 0.17 | 0.14 | 0.12 | 0.19 | |
| Free cash flow yield | -0.41 | -0.21 | 0.48 | 0.01 | -0.08 | |
| Debt to equity | 2.49 | 2.35 | 2.24 | 2.18 | 2.16 | |
| Debt to assets | 0.6 | 0.6 | 0.58 | 0.58 | 0.57 | |
| Net debt to EBITDA | 5.53 | 6.99 | 5.39 | 6.02 | 6.23 | |
| Current ratio | 1.82 | 1.68 | 1.76 | 2.26 | 1.9 | |
| Interest coverage | 11.81 | 9.11 | 10.38 | 8.8 | 6.77 | |
| Income quality | 1.34 | 3.49 | 5.09 | 3.67 | 2.45 | |
| Dividend Yield | 0.03 | 0.05 | 0.05 | 0.05 | 0.05 | |
| Payout ratio | 0.22 | 0.27 | 0.34 | 0.39 | 0.24 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Capex to operating cash flow | -3.07 | -1.36 | -0.62 | -0.98 | -1.11 | |
| Capex to revenue | -0.27 | -0.23 | -0.17 | -0.17 | -0.16 | |
| Capex to depreciation | -14.29 | -11.4 | -13.01 | -12.7 | -8.11 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 779.73 | 765.35 | 722.59 | 697.89 | 836.6 | |
| ROIC | 0.08 | 0.05 | 0.06 | 0.06 | 0.06 | |
| Return on tangible assets | 0.04 | 0.04 | 0.03 | 0.02 | 0.03 | |
| Graham Net | -661.55 | -751.42 | -680.91 | -681.4 | -777.3 | |
| Working capital | 46.62B | 39.97B | 49.7B | 70.04B | 67.62B | |
| Tangible asset value | 41.09B | 45.89B | 49.35B | 53.03B | 57.09B | |
| Net current asset value | -31.57B | -38.65B | -29B | -24B | -21.25B | |
| Invested capital | 2.49 | 2.35 | 2.24 | 2.18 | 2.16 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 13.98B | 11.79B | 9.82B | 12.59B | 14.36B | |
| Average inventory | 59.27B | 68.9B | 69.78B | 71.7B | 82.35B | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 67.73 | 27.05 | 31.37 | 41.03 | 43.39 | |
| Days of inventory on hand | 294.31 | 240.28 | 186.13 | 225.05 | 258.11 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 5.39 | 13.49 | 11.64 | 8.9 | 8.41 | |
| Inventory turnover | 1.24 | 1.52 | 1.96 | 1.62 | 1.41 | |
| ROE | 0.17 | 0.14 | 0.11 | 0.09 | 0.1 | |
| Capex per share | -279.93 | -281.74 | -271.93 | -238.19 | -235.95 |
Quarterly Fundamentals Overview
Last date of statement is 2022-12-31 for Q3
| Metric | History | 2021-12-31 | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 |
|---|---|---|---|---|---|---|
| Revenue per share | 459.66 | 577.07 | 259.74 | 413.99 | 198.16 | |
| Net income per share | 35.42 | 24.04 | 1.89 | 24.47 | -11.73 | |
| Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
| Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
| Cash per share | 339.93 | 307.65 | 289.41 | 388.04 | 363.28 | |
| Book value per share | 518.1 | 545.82 | 530.99 | 558.75 | 540.83 | |
| Tangible book value per share | 491.09 | 525.42 | 510.16 | 538.39 | 448.4 | |
| Share holders equity per share | 518.1 | 545.82 | 530.99 | 558.75 | 540.83 | |
| Interest debt per share | 1.29K | 1.18K | 1.41K | 1.45K | 2.16K | |
| Market cap | 31.4B | 32.49B | 39.26B | 41.98B | 40.35B | |
| Enterprise value | 133.74B | 127.03B | 160.98B | 157.79B | 236.34B | |
| P/E ratio | 2.04 | 3.11 | 47.64 | 3.93 | -7.89 | |
| Price to sales ratio | 0.63 | 0.52 | 1.39 | 0.93 | 1.87 | |
| POCF ratio | 0 | 0 | 0 | 0 | 0 | |
| PFCF ratio | 0 | 0 | 0 | 0 | 0 | |
| P/B Ratio | 0.56 | 0.55 | 0.68 | 0.69 | 0.68 | |
| PTB ratio | 0.56 | 0.55 | 0.68 | 0.69 | 0.68 | |
| EV to sales | 2.68 | 2.03 | 5.68 | 3.5 | 10.94 | |
| Enterprise value over EBITDA | 22.69 | 23.46 | 212.38 | 41.49 | -147.44 | |
| EV to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| EV to free cash flow | 0 | 0 | 0 | 0 | 0 | |
| Earnings yield | 0.12 | 0.08 | 0.01 | 0.06 | -0.03 | |
| Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
| Debt to equity | 2.47 | 2.16 | 2.65 | 2.6 | 3.99 | |
| Debt to assets | 0.61 | 0.57 | 0.63 | 0.63 | 0.72 | |
| Net debt to EBITDA | 17.36 | 17.46 | 160.58 | 30.45 | -122.27 | |
| Current ratio | 2.07 | 1.9 | 1.98 | 2.05 | 1.51 | |
| Interest coverage | 11.45 | 16.01 | 1.66 | 9.54 | -4.52 | |
| Income quality | 0 | 0 | 0 | 0 | 0 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.04 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 642.61 | 543.35 | 150.23 | 554.7 | 377.78 | |
| ROIC | 0.03 | 0.02 | 0 | 0.02 | -0.01 | |
| Return on tangible assets | 0.02 | 0.01 | 0 | 0.01 | 0 | |
| Graham Net | -767.19 | -778.73 | -880.21 | -833.27 | -1.49K | |
| Working capital | 79.76B | 67.62B | 82.04B | 88.49B | 61.5B | |
| Tangible asset value | 53.36B | 57.09B | 55.63B | 58.71B | 48.9B | |
| Net current asset value | -16B | -21.25B | -19.54B | -18.13B | -83.22B | |
| Invested capital | 2.47 | 2.16 | 2.65 | 2.6 | 3.99 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 8.33B | 12.43B | 13.95B | 11.53B | 9.06B | |
| Average inventory | 105.56B | 96.1B | 103.74B | 115.41B | 120.98B | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 21.81 | 27.22 | 49.99 | 26.54 | 39.11 | |
| Days of inventory on hand | 232.12 | 161.9 | 463.54 | 288.77 | 657.41 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 4.13 | 3.31 | 1.8 | 3.39 | 2.3 | |
| Inventory turnover | 0.39 | 0.56 | 0.19 | 0.31 | 0.14 | |
| ROE | 0.07 | 0.04 | 0 | 0.04 | -0.02 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
8897.T Frequently Asked Questions
What is Takara Leben Co., Ltd. stock symbol ?
Takara Leben Co., Ltd. is a JP stock and trading under the symbol 8897.T
What is Takara Leben Co., Ltd. stock quote today ?
Takara Leben Co., Ltd. stock price is $435 today.
Is Takara Leben Co., Ltd. stock public?
Yes, Takara Leben Co., Ltd. is a publicly traded company.
Company Profile
- Volume Average 360.49K
- Market Capitalization 47.55B
- Employee 1.2K
- CEO Mr. Kazuichi Shimada
- Headquarters Tokyo,JP
- IPO Date 2003-04-04
-
Website
https://www.leben.co.jp 
Takara Leben Co., Ltd. engages in the real estate business in Japan. It plans, designs, develops, and sells condominiums under the LEBEN brand names. The company engages in the electric power generation business; and condominium management services. In addition, it is involved in the real estate sales, agency, distribution, and brokerage; construction activities; renewal resale and loan collection; and investment management, type II financial instruments services, investment advisory and agency, and REIT's asset management businesses. The company was formerly known as Takara Komuten Co., Ltd. and changed its name to Takara Leben Co., Ltd. in 2000. Takara Leben Co., Ltd. was founded in 1972 and is headquartered in Tokyo, Japan.
